Reed & Carnrick
Executive Summary
Files application with FDA to export bulk sodium aminosalicylate (4-ASA) to the UK for use in treatment of mild to moderate ulcerative colitis and an adjunct in severe colitis. Reid-Rowell had a 5-ASA product approved by FDA on Dec. 28 for similar indications.